221 related articles for article (PubMed ID: 19916962)
21. The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms.
Ray DM; Akbiyik F; Phipps RP
J Immunol; 2006 Oct; 177(8):5068-76. PubMed ID: 17015690
[TBL] [Abstract][Full Text] [Related]
22. Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2.
Butler R; Mitchell SH; Tindall DJ; Young CY
Cell Growth Differ; 2000 Jan; 11(1):49-61. PubMed ID: 10672903
[TBL] [Abstract][Full Text] [Related]
23. Induction of the permeability transition and cytochrome c release by 15-deoxy-Delta12,14-prostaglandin J2 in mitochondria.
Landar A; Shiva S; Levonen AL; Oh JY; Zaragoza C; Johnson MS; Darley-Usmar VM
Biochem J; 2006 Feb; 394(Pt 1):185-95. PubMed ID: 16268779
[TBL] [Abstract][Full Text] [Related]
24. Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12,14-prostaglandin J2.
Lee TS; Tsai HL; Chau LY
J Biol Chem; 2003 May; 278(21):19325-30. PubMed ID: 12642589
[TBL] [Abstract][Full Text] [Related]
25. 15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism.
Kang DS; Kwon CH; Park JY; Kim JH; Woo JS; Jung JS; Kim YK
Toxicol Appl Pharmacol; 2006 Nov; 216(3):426-35. PubMed ID: 16890972
[TBL] [Abstract][Full Text] [Related]
26. 15-Deoxy-Δ
Nilsson L; Palm F; Nørregaard R
Mediators Inflamm; 2017; 2017():3924912. PubMed ID: 28503033
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
Moriai M; Tsuji N; Kobayashi D; Kuribayashi K; Watanabe N
Int J Oncol; 2009 May; 34(5):1363-72. PubMed ID: 19360348
[TBL] [Abstract][Full Text] [Related]
28. Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species.
Landar A; Zmijewski JW; Dickinson DA; Le Goffe C; Johnson MS; Milne GL; Zanoni G; Vidari G; Morrow JD; Darley-Usmar VM
Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1777-87. PubMed ID: 16387790
[TBL] [Abstract][Full Text] [Related]
29. 15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) protects neurons from oxidative death via an Nrf2 astrocyte-specific mechanism independent of PPARγ.
Haskew-Layton RE; Payappilly JB; Xu H; Bennett SA; Ratan RR
J Neurochem; 2013 Feb; 124(4):536-47. PubMed ID: 23199167
[TBL] [Abstract][Full Text] [Related]
30. Physiological and Pathological Roles of 15-Deoxy-Δ
Yagami T; Yamamoto Y; Koma H
Mol Neurobiol; 2018 Mar; 55(3):2227-2248. PubMed ID: 28299574
[TBL] [Abstract][Full Text] [Related]
31. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
Haslmayer P; Thalhammer T; Jäger W; Aust S; Steiner G; Ensinger C; Obrist P
Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
[TBL] [Abstract][Full Text] [Related]
32. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-alpha but not peroxisome proliferator-activated receptor-gamma in human vascular endothelial cells: the effect of 15d-PGJ2 on tumor necrosis factor-alpha-induced gene expression.
Migita H; Morser J
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):710-6. PubMed ID: 15662020
[TBL] [Abstract][Full Text] [Related]
33. 15-deoxy-delta 12,14-prostaglandin J2 and laminar fluid shear stress stabilize c-IAP1 in vascular endothelial cells.
Taba Y; Miyagi M; Miwa Y; Inoue H; Takahashi-Yanaga F; Morimoto S; Sasaguri T
Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H38-46. PubMed ID: 12623786
[TBL] [Abstract][Full Text] [Related]
34. 15-Deoxy-delta12,14-prostaglandin J2 induces apoptosis of a thyroid papillary cancer cell line (CG3 cells) through increasing intracellular iron and oxidative stress.
Chen SY; Lu FJ; Gau RJ; Yang ML; Huang TS
Anticancer Drugs; 2002 Aug; 13(7):759-65. PubMed ID: 12187333
[TBL] [Abstract][Full Text] [Related]
35. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss.
Kim KR; Kim HJ; Lee SK; Ma GT; Park KK; Chung WY
PLoS One; 2015; 10(4):e0122764. PubMed ID: 25859665
[TBL] [Abstract][Full Text] [Related]
36. Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Delta12,14-prostaglandin J2 in human oral squamous carcinoma cells.
Siavash H; Nikitakis NG; Sauk JJ
Cancer Lett; 2004 Jul; 211(1):97-103. PubMed ID: 15194221
[TBL] [Abstract][Full Text] [Related]
37. Rac1 modification by an electrophilic 15-deoxy Δ(12,14)-prostaglandin J2 analog.
Wall SB; Oh JY; Mitchell L; Laube AH; Campbell SL; Renfrow MB; Landar A
Redox Biol; 2015; 4():346-54. PubMed ID: 25677088
[TBL] [Abstract][Full Text] [Related]
38. 15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂ as an electrophilic mediator.
Shibata T
Biosci Biotechnol Biochem; 2015; 79(7):1044-9. PubMed ID: 26011133
[TBL] [Abstract][Full Text] [Related]
39. 15-deoxy-delta12,14-prostaglandin J2 regulates the functional state and the survival of microglial cells through multiple molecular mechanisms.
Bernardo A; Ajmone-Cat MA; Levi G; Minghetti L
J Neurochem; 2003 Nov; 87(3):742-51. PubMed ID: 14535956
[TBL] [Abstract][Full Text] [Related]
40. 15-Deoxy-Δ
Choi JE; Kim JH; Song NY; Suh J; Kim DH; Kim SJ; Na HK; Nadas J; Dong Z; Cha YN; Surh YJ
Free Radic Res; 2016 Oct; 50(10):1140-1152. PubMed ID: 27598034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
